Skip to main content

Table 1 Sociodemographic and other characteristics of the patients (N = 206)a

From: Validation of the Arabic version of the “self-evaluation of negative symptoms” scale (SNS)

 

Frequency (%)

Gender

Men

89 (43.2%)

Women

117 (56.8%)

Marital status

Single

168 (82%)

Married

28 (13.7%)

Divorced

9 (4.3%)

Educational level

Primary

128 (63.4%)

Secondary

57 (28.2%)

University

17 (8.4%)

Intake of psychoactive substances

No

196 (95.1%)

Yes

10 (4.9%)

Alcohol intake

No

189 (92.2%)

Yes

16 (7.8%)

Smoking

No

90 (43.9%)

Yes

115 (56.1%)

Presence of family history of schizophrenic episodes

No

162 (78.6%)

Yes

44 (21.4%)

Presence of family history of other psychiatric diseases

No

185 (89.9%)

Yes

21 (10.2%)

 

Mean ± Standard Deviation

Age (in years)

52.68 ± 12.00

Chlorpromazine total equivalent dose (in mg)

1150.91 ± 973.70

Chlorpromazine equivalent dose for typical antipsychotics (in mg)

1010.57 ± 973.63

Chlorpromazine equivalent dose for atypical antipsychotics (in mg)

163.57 ± 305.97

  1. a Some variables did not sum up to 206 due to missing data